This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Obesity is one of the biggest global health concerns we face today. Obesity is also a key driver of risk for cardiovascular disease. Although there are many factors linked to obesity, one factor is certain: excess caloric intake leads to an excess in the energy balance. 2023 Jul;4(7):e345-e353. Obesity (Silver Spring).
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. vs 61.07, p < 0.01), more often obese (12.15% vs 9.32%, p < 0.01), of the white race (55.82% vs 51%, p < 0.01), and considered long‐term users of anticoagulants (8.12% vs 5.34%, p < 0.01) when compared to the non‐AKI group.
The Global Burden of Disease data (2023) highlights a grim reality: while high-income countries have seen some success in managing CVD, LMICs now account for most CVD-related deaths. This imbalance is partly due to limited healthcare access, fewer preventive resources, and challenges in addressing risk factors such as obesity and diabetes.
Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.
New obesity medications such as GLP-1 agonists have shown significant reductions in weight in those with a prior heart attack. 2 Trends and Predictors of Participation in Cardiac Rehabilitation Following Acute MyocardialInfarction: Data From the Behavioral Risk Factor Surveillance System. 2023 Nov 11. J Am Heart Assoc.
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardialinfarction (MI), stroke, and cardiovascular (CV) death.4 As of June 2023, the U.S. Accessed November 8, 2023. Accessed January 18, 2023. AGEPHA Pharma FZ LLC; 2023. 4 In the U.S.
Another study published in January 2023 in the Journal of the American Heart Association evaluated data from 593, 616 young adults, and found that depression and poor mental health are associated with premature CVD as well as suboptimal cardiovascular health (CVH). 2023 Jul 5;11(7):1903. JAMA Netw Open. 2021;4(12):e2138920.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 37.6%, p < 0.001), obesity (9.2% CM‐HF patients had higher rates of in‐patient complications such as PEG placement, tracheostomy, sepsis, DVT or PE, pneumonia, UTI, AKI, myocardialinfarction, and intracerebral hemorrhage.
Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD). million. HCP Live.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content